{"count": 4, "results": [{"_id": "35216477", "pmid": 35216477, "pmcid": "PMC8875586", "title": "Metformin: Expanding the Scope of Application:Starting Earlier than Yesterday, Canceling Later", "journal": "Int J Mol Sci", "authors": ["Kononova YA", "Likhonosov NP", "Babenko AY"], "date": "2022-02-21T00:00:00Z", "doi": "10.3390/ijms23042363", "meta_date_publication": "2022 Feb 21", "meta_volume": "23", "meta_issue": "4", "meta_pages": "", "score": 50271.664, "text_hl": "Today the area of application of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is expanding, and a wealth of data point to its benefits in people without @<m>DISEASE_Carbohydrate_Metabolism_Inborn_Errors</m> @DISEASE_MESH:D002239 @@@carbohydrate metabolism disorders@@@. ", "citations": {"NLM": "Kononova YA, Likhonosov NP, Babenko AY. Metformin: Expanding the Scope of Application:Starting Earlier than Yesterday, Canceling Later Int J Mol Sci. 2022 Feb 21;23(4):. PMID: 35216477", "BibTeX": "@article{35216477, title={Metformin: Expanding the Scope of Application:Starting Earlier than Yesterday, Canceling Later}, author={Kononova YA and Likhonosov NP and Babenko AY}, journal={Int J Mol Sci}, volume={23}, number={4}}"}}, {"_id": "36519659", "pmid": 36519659, "title": "Use of metformin in patients who require intravascular administration of a contrast agent.", "journal": "Endokrynol Pol", "authors": ["Rokicka D", "Wróbel M", "Stołtny D", "Strojek K"], "date": "2022-01-01T00:00:00Z", "doi": "10.5603/EP.a2022.0079", "meta_date_publication": "2022", "meta_volume": "73", "meta_issue": "6", "meta_pages": "913-916", "score": 50266.87, "text_hl": "Many @SPECIES_9606 @@@patients@@@ using @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, due to complications of @<m>DISEASE_Carbohydrate_Metabolism_Inborn_Errors</m> @DISEASE_MESH:D002239 @@@carbohydrate metabolism disorders@@@, including @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular complications@@@ or other accompanying diseases, require cardiological or radiological diagnostics related to the administration of a contrast agent. ", "citations": {"NLM": "Rokicka D, Wróbel M, Stołtny D, Strojek K. Use of metformin in patients who require intravascular administration of a contrast agent. Endokrynol Pol. 2022;73(6):913-916. PMID: 36519659", "BibTeX": "@article{36519659, title={Use of metformin in patients who require intravascular administration of a contrast agent.}, author={Rokicka D and Wróbel M and Stołtny D and Strojek K}, journal={Endokrynol Pol}, volume={73}, number={6}, pages={913-916}}"}}, {"_id": "12038076", "pmid": 12038076, "title": "[Metformin has a positive effect on disorders of carbohydrate metabolism in long-term care with low doses of prednisone].", "journal": "Cas Lek Cesk", "authors": ["Vondra K", "Nĕmcová D", "Stárka L", "Bílek R", "Bendlová B", "Hampl R", "Hill M", "Hoza J", "Kot'átková A", "Vrbíková J", "Zamrazil V"], "date": "2002-04-26T00:00:00Z", "meta_date_publication": "2002 Apr 26", "meta_volume": "141", "meta_issue": "8", "meta_pages": "255-60", "score": 50073.508, "text_hl": "[@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has a positive effect on @<m>DISEASE_Carbohydrate_Metabolism_Inborn_Errors</m> @DISEASE_MESH:D002239 @@@disorders of carbohydrate metabolism@@@ in long-term care with low doses of @CHEMICAL_Prednisone @CHEMICAL_MESH:D011241 @@@prednisone@@@].", "citations": {"NLM": "Vondra K, Nĕmcová D, Stárka L, Bílek R, Bendlová B, Hampl R, Hill M, Hoza J, Kot'átková A, Vrbíková J, Zamrazil V. [Metformin has a positive effect on disorders of carbohydrate metabolism in long-term care with low doses of prednisone]. Cas Lek Cesk. 2002 Apr 26;141(8):255-60. PMID: 12038076", "BibTeX": "@article{12038076, title={[Metformin has a positive effect on disorders of carbohydrate metabolism in long-term care with low doses of prednisone].}, author={Vondra K and Nĕmcová D and Stárka L and Bílek R and Bendlová B and Hampl R and Hill M and Hoza J and Kot'átková A and Vrbíková J and Zamrazil V}, journal={Cas Lek Cesk}, volume={141}, number={8}, pages={255-60}}"}}, {"_id": "15759454", "pmid": 15759454, "title": "[Clinicogenetic aspects of carbohydrate metabolism disorders and efficacy of their correction with moxonidine and metformine in patients with arterial hypertension].", "journal": "Ter Arkh", "authors": ["Kobalava ZhD", "Tolkacheva VV", "Ignat'ev IV", "Glezer MG", "Kuzin AI", "Karpov IuA", "Konradi AO", "Zheleznykh EA"], "date": "2005-01-01T00:00:00Z", "meta_date_publication": "2005", "meta_volume": "77", "meta_issue": "1", "meta_pages": "46-51", "score": 50068.64, "text_hl": "[Clinicogenetic aspects of @<m>DISEASE_Carbohydrate_Metabolism_Inborn_Errors</m> @DISEASE_MESH:D002239 @@@carbohydrate metabolism disorders@@@ and efficacy of their correction with @CHEMICAL_moxonidine @CHEMICAL_MESH:C043482 @@@moxonidine@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformine@@@ in @SPECIES_9606 @@@patients@@@ with arterial @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@].", "citations": {"NLM": "Kobalava ZhD, Tolkacheva VV, Ignat'ev IV, Glezer MG, Kuzin AI, Karpov IuA, Konradi AO, Zheleznykh EA. [Clinicogenetic aspects of carbohydrate metabolism disorders and efficacy of their correction with moxonidine and metformine in patients with arterial hypertension]. Ter Arkh. 2005;77(1):46-51. PMID: 15759454", "BibTeX": "@article{15759454, title={[Clinicogenetic aspects of carbohydrate metabolism disorders and efficacy of their correction with moxonidine and metformine in patients with arterial hypertension].}, author={Kobalava ZhD and Tolkacheva VV and Ignat'ev IV and Glezer MG and Kuzin AI and Karpov IuA and Konradi AO and Zheleznykh EA}, journal={Ter Arkh}, volume={77}, number={1}, pages={46-51}}"}}]}